×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KROS – keros therapeutics, inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KROS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/7
11:14 am
kros
Keros Therapeutics, Inc. (NASDAQ: KROS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $84.00 price target on the stock.
Low
Report
Keros Therapeutics, Inc. (NASDAQ: KROS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $84.00 price target on the stock.
11/7
08:36 am
kros
Keros Therapeutics, Inc. (NASDAQ: KROS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Low
Report
Keros Therapeutics, Inc. (NASDAQ: KROS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
11/6
04:13 pm
kros
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results [Yahoo! Finance]
11/6
04:01 pm
kros
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results
Low
Report
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results
11/6
08:00 am
kros
Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference
Low
Report
Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference
11/6
06:33 am
kros
Keros Therapeutics, Inc. (NASDAQ: KROS) was upgraded by analysts at Wedbush to a "strong-buy" rating.
Medium
Report
Keros Therapeutics, Inc. (NASDAQ: KROS) was upgraded by analysts at Wedbush to a "strong-buy" rating.
11/5
02:01 pm
kros
Keros Therapeutics, Inc. (NASDAQ: KROS) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Low
Report
Keros Therapeutics, Inc. (NASDAQ: KROS) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
11/5
09:00 am
kros
Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition
Medium
Report
Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2024
04:01 pm
KROS
keros therapeutics, inc. - common stock
MISS
Report
1.1%
keros therapeutics, inc. - common stock
8/7/2024
04:01 pm
KROS
keros therapeutics, inc. - common stock
MISS
Report
-2.2%
keros therapeutics, inc. - common stock
5/8/2024
08:00 am
KROS
keros therapeutics, inc. - common stock
BEAT
Report
-0.6%
keros therapeutics, inc. - common stock
2/28/2024
04:01 pm
KROS
keros therapeutics, inc. - common stock
BEAT
Report
-0.8%
keros therapeutics, inc. - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
04:16 pm
kros
Form 4 Keros Therapeutics, Inc. For: Nov 08 Filed by: CHYUNG YUNG H.
Low
Report
Form 4 Keros Therapeutics, Inc. For: Nov 08 Filed by: CHYUNG YUNG H.
11/8
04:20 pm
kros
Form 3 Keros Therapeutics, Inc. For: Nov 01 Filed by: CHYUNG YUNG H.
Low
Report
Form 3 Keros Therapeutics, Inc. For: Nov 01 Filed by: CHYUNG YUNG H.
11/6
04:23 pm
kros
Form 10-Q Keros Therapeutics, Inc. For: Sep 30
Low
Report
Form 10-Q Keros Therapeutics, Inc. For: Sep 30
11/6
04:02 pm
kros
Form 8-K Keros Therapeutics, Inc. For: Nov 06
Low
Report
Form 8-K Keros Therapeutics, Inc. For: Nov 06
11/6
08:02 am
kros
Form 8-K Keros Therapeutics, Inc. For: Nov 06
Low
Report
Form 8-K Keros Therapeutics, Inc. For: Nov 06
10/16
08:01 am
kros
Form 8-K Keros Therapeutics, Inc. For: Oct 15
Low
Report
Form 8-K Keros Therapeutics, Inc. For: Oct 15
9/30
08:00 am
kros
Form 8-K Keros Therapeutics, Inc. For: Sep 30
Low
Report
Form 8-K Keros Therapeutics, Inc. For: Sep 30
9/3
08:02 am
kros
Form 8-K Keros Therapeutics, Inc. For: Sep 03
Medium
Report
Form 8-K Keros Therapeutics, Inc. For: Sep 03
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/13
Keros Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
18.3%
4/8 Form 424B4 Keros Therapeutics, Inc. 7.4%
4/20 Form SC 13D Keros Therapeutics, Inc. Filed by: Arkin Moshe 6.5%
4/11 U.S. IPO Weekly Recap: Keros Therapeutics Rises 35% As Biotechs Beat The IPO Shutdown [Seeking Alpha] 5.7%
4/23 Form SC 13D Keros Therapeutics, Inc. Filed by: Pontifax Management 4 G.P. (2015) Ltd. 3.8%
4/8 Form 424B4 Keros Therapeutics, Inc. 7.4%
4/20 Form SC 13D Keros Therapeutics, Inc. Filed by: Arkin Moshe 6.5%
4/11 U.S. IPO Weekly Recap: Keros Therapeutics Rises 35% As Biotechs Beat The IPO Shutdown [Seeking Alpha] 5.7%
4/23 Form SC 13D Keros Therapeutics, Inc. Filed by: Pontifax Management 4 G.P. (2015) Ltd. 3.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: